1. Ahmad S. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics. Medical Hypotheses. 2002;58 (4):327-31.
2. Kumari S, Harjai K, Chhibber S. Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. Journal of Medical Microbiology. 2011;60(2):205-10.
3. Soheili V, Bazzaz BSF, Abdollahpour N, Hadizadeh F. Investigation of Pseudomonas aeruginosa quorum-sensing signaling system for identifying multiple inhibitors using molecular docking and structural analysis methodology. Microbial Pathogenesis. 2015;89:73-8.
4. Soothill J. Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections. Expert Review of Anti-infective Therapy. 2013;11(9):909-15.
5. Jault P, Leclerc T, Jennes S, Pirnay JP, Que Y-A, Resch G, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. The Lancet Infectious Diseases. 2019;19(1):35-45.
6. Criscuolo E, Spadini S, Lamanna J, Ferro M, Burioni R. Bacteriophages and their immunological applications against infectious threats. Journal of Iimmunology Rresearch. 2017;2017.
7. Aghaee BL, Khan Mirzaei M, Alikhani MY, Mojtahedi A, Maurice CF. Improving the Inhibitory Effect of phages against Pseudomonas aeruginosa isolated from a burn patient using a combination ofphages and antibiotics. Viruses. 2021;13(2):334.
8. Lopez S, Arias C. How viruses hijack endocytic machinery. Nature Education. 2010;3(9):16.
9. Principi N, Silvestri E, Esposito S. Advantages and limitations of bacteriophages for the treatment of bacterial infections. Frontiers in Pharmacology. 2019;10:513.
10. Pinto AM, Cerqueira MA, Bañobre-Lópes M, Pastrana LM, Sillankorva S. Bacteriophages for chronic wound treatment: From traditional to novel delivery systems. Viruses. 2020;12(2):235.
11. Goode D, Allen V, Barrow P. Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Applied and Environmental Microbiology. 2003;69(8):5032-6.
12. Kumari S, Harjai K, Chhibber S. Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. The Journal of Infection in Developing Countries. 2010;4(06):367-77.
13. Brown TL, Petrovski S, Dyson ZA, Seviour R, Tucci J. The formulation of bacteriophage in a semi solid preparation for control of Propionibacterium acnes growth. PLoS One. 2016;11(3).
14. Chadha P, Katare OP, Chhibber S. Liposome loaded phage cocktail: enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections. Burns. 2017;43(7):1532-43.
15. Kumari S, Harjai K, Chhibber S. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. Journal of Microbiology and Biotechnology. 2009;19(6):622-8.
16. McVay CS, Velásquez M, Fralick JA. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrobial Agents and Chemotherapy. 2007;51(6):1934-8.
17. Calum H, Høiby N, Moser C. Burn mouse models. Pseudomonas methods and protocols: Springer; 2014. p. 793-802.
18. Tkalčević VI, Čužić S, Parnham MJ, Pašalić I, Brajša K. Differential evaluation of excisional non-occluded wound healing in db/db mice. Toxicologic Pathology. 2009;37(2):183-92.
19. Rose T, Verbeken G, De Vos D, Merabishvili M, Vaneechoutte M, Lavigne R, et al. Experimental phage therapy of burn wound infection: difficult first steps. International Journal of Burns and Trauma. 2014;4(2):66.
20. Karamoddini MK, Fazli-Bazzaz B, Emamipour F, Ghannad MS, Jahanshahi A, Saed N, et al. Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species. The Scientific World Journal. 2011;11.
21. Merabishvili M, Monserez R, Van Belleghem J, Rose T, Jennes S, De Vos D, et al. Stability of bacteriophages in burn wound care products. PLoS One. 2017;12(7):e0182121.
22. Chang RYK, Morales S, Okamoto Y, Chan H-K. Topical application of bacteriophages for treatment of wound infections. Translational Research. 2020; 220:153-166.
23. Brown TL, Thomas T, Odgers J, Petrovski S, Spark MJ, Tucci J. Bacteriophage formulated into a range of semisolid and solid dosage forms maintain lytic capacity against isolated cutaneous and opportunistic oral bacteria. Journal of Pharmacy and Pharmacology. 2017;69(3):244-53.
24. Brown TL, Ku H, Mnatzaganian G, Angove M, Petrovski S, Kabwe M, et al. The varying effects of a range of preservatives on Myoviridae and Siphoviridae bacteriophages formulated in a semisolid cream preparation. Letters in Applied Microbiology. 2020.
25. Holguín AV, Rangel G, Clavijo V, Prada C, Mantilla M, Gomez MC, et al. Phage ΦPan70, a putative temperate phage, controls Pseudomonas aeruginosa in planktonic, biofilm and burn mouse model assays. Viruses. 2015;7(8):4602-23.
26. Fukui T, Kawaguchi AT, Takekoshi S, Miyasaka M, Sumiyoshi H, Tanaka R. Liposome‐encapsulated hemoglobin accelerates skin wound healing in diabetic dB/dB mice. Artificial Organs. 2017;41(4):319-26.
27. Park SA, Raghunathan VK, Shah NM, Teixeira L, Motta MJ, Covert J, et al. PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds. PLoS One. 2014;9(8):e104447.
28. Górski A, Jończyk-Matysiak E, Międzybrodzki R, Weber-Dąbrowska B, Łusiak-Szelachowska M, Bagińska N, et al. Phage therapy: beyond antibacterial action. Frontiers in Medicine. 2018;5:146.